ZCL278 is a selective Cdc42 GTPase inhibitor.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 97 | |
10 mg | In stock | $ 174 | |
20 mg | In stock | $ 278 | |
50 mg | In stock | $ 547 | |
100 mg | In stock | $ 853 |
Description | ZCL278 is a selective Cdc42 GTPase inhibitor. |
Targets&IC50 | Cdc42 GTPase:11.4 μM(Kd) |
In vivo | ZCL278 reduces the JUNV RNA load in the spleen more than 33-fold, with JUNV RNA being undetectable in 5 out of 8 mice. These results are similar to those seen in Gabapentin-treated mice, demonstrating that ZCL278 can abrogate JUNV replication. |
Synonyms | ZCL 278 |
CAS No. | 587841-73-4 |
Chemical Formula | C21H19BrClN5O4S2 |
Molecular Weight | 584.89 |
Solubility | DMSO: 58.5 mg/mL (100 mM) |
Storage | Powder: -20°C for 2 years In solvent: -80°C for 1 year |
bottom